Fig. 1From: Uncarboxylated osteocalcin alleviates the inhibitory effect of high glucose on osteogenic differentiation of mouse bone marrow–derived mesenchymal stem cells by regulating TP63Effects of HG or GluOC on BMSCs. Results of the three treatment groups are shown: normal group (NG; glucose 5.5 mM), high glucose group (HG; glucose 25.5 mM), high glucose plus uncarboxylated osteocalcin group (HG + GluOC; glucose 25.5 mm and GluOC 3 ng/mL). a Relative mRNA expression levels of osteogenic genes (RUNX2, OSX, ALP); b relative mRNA expression levels of lipogenic genes (PPARγ, Ap2, FAS). c Western Blot images of RUNX2 and β-actin are shown; the relative protein expression level is calculated according to the gray value. d Intracellular ALP activity and (e) Collagen I level. *P < 0.05, **P < 0.01 versus NG; #P < 0.05, ##P < 0.01 versus HGBack to article page